Hearing:
Improving Predictability and Transparency in DEA and FDA Regulation
Subcommittee on Health (Committee on Energy and Commerce)
Monday, April 7, 2014 (3:00 PM)
2123 RHOB
Washington, D.C.
Witnesses
Mr. Joseph T. Rannazzisi
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Control, U.S. Department of Justice, Springfield, VA
Added
04/04/2014 at 10:42 AM
- Witness Statement
[PDF]
Added
04/05/2014 at 01:24 PM
- Questions for the Record letter
[PDF]
Added
07/09/2014 at 03:22 PM
- QFR Response
[PDF]
Added
05/01/2015 at 04:19 PM
- Witness Truth in Testimony
[PDF]
Added
04/04/2014 at 02:59 PM
- Witness Biography
[PDF]
Added
04/04/2014 at 02:59 PM
Mr. D. Linden Barber
Partner and Director, DEA Compliance Practice, Quarles & Brady LLP, Washington, D.C.
Added
04/04/2014 at 10:42 AM
- Witness Statement
[PDF]
Added
04/04/2014 at 03:36 PM
- Questions for the Record letter
[PDF]
Added
07/09/2014 at 03:22 PM
- Questions for the Record response
[PDF]
Added
07/09/2014 at 03:22 PM
- Witness Truth in Testimony
[PDF]
Added
04/04/2014 at 02:59 PM
- Witness Biography
[PDF]
Added
04/04/2014 at 02:59 PM
Mr. Scott Faber
Vice President of Government Affairs, Environmental Working Group, Washington, D.C.
Added
04/04/2014 at 02:59 PM
- Witness Statement
[PDF]
Added
04/06/2014 at 06:20 PM
- Witness Truth in Testimony
[PDF]
Added
04/07/2014 at 09:04 AM
- Witness Biography
[PDF]
Added
04/07/2014 at 09:04 AM
Dr. Nathan B. Fountain
Professor of Neurology and Director, F.E. Dreifuss Comprehensive Epilepsy Program, University of Virginia, Charlottesville, VA
Added
04/04/2014 at 10:42 AM
- Witness Statement
[PDF]
Added
04/04/2014 at 02:59 PM
- Witness Truth in Testimony
[PDF]
Added
04/04/2014 at 02:59 PM
- Witness Biography
[PDF]
Added
04/04/2014 at 03:36 PM
Mr. John M. Gray
President and CEO, Healthcare Distribution Management Association, Arlington, VA
Added
04/04/2014 at 10:42 AM
- Witness Statement
[PDF]
Added
04/04/2014 at 02:59 PM
- Witness Truth in Testimony
[PDF]
Added
04/04/2014 at 02:59 PM
- Witness Biography
[PDF]
Added
04/04/2014 at 02:59 PM
Ms. Wendy K.D. Selig
President and CEO, Melanoma Research Alliance, Washington, D.C.
Added
04/04/2014 at 10:42 AM
- Witness Statement
[PDF]
Added
04/04/2014 at 04:59 PM
- Witness Truth in Testimony
[PDF]
Added
04/04/2014 at 04:59 PM
- Witness Biography
[PDF]
Added
04/04/2014 at 04:59 PM
Dr. Janet Woodcock
Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
Added
04/04/2014 at 10:42 AM
- Witness Statement
[PDF]
Added
04/04/2014 at 02:59 PM
- Questions for the Record Enclosure
[PDF]
Added
07/09/2014 at 03:22 PM
- Questions for the Record Response
[PDF]
Added
01/09/2015 at 01:21 PM
- Witness Truth in Testimony
[PDF]
Added
04/04/2014 at 02:59 PM
- Witness Biography
[PDF]
Added
04/04/2014 at 02:59 PM
Text of Legislation
- H.R. 4299, the "Improving Regulatory Transparency for New Medical Therapies Act"
[PDF]
- H.R. 4069, the "Ensuring Patient Access and Effective Drug Enforcement Act"
[PDF]
- H.R. 4250, the "Sunscreen Innovation Act"
[PDF]
Support Documents
- Hearing Notice
[PDF]
- Hearing Memo
[PDF]
Added
04/04/2014 at 10:37 AM
- Opening Statement by Subcommittee Chairman Pitts
[PDF]
Added
04/07/2014 at 05:11 PM
- Opening Statement of Committee Chairman Upton
[PDF]
Added
04/07/2014 at 05:11 PM
- Document for the Record, AADA
[PDF]
Added
04/07/2014 at 05:11 PM
- Document for the Record, APAM
[PDF]
Added
04/07/2014 at 05:11 PM
- Document for the Record, DPA
[PDF]
Added
04/07/2014 at 05:11 PM
- Document for the Record, Fed Ex
[PDF]
Added
04/07/2014 at 05:11 PM
- Document for the Record, GHLF
[PDF]
Added
04/07/2014 at 05:11 PM
- Document for the Record, NACDS
[PDF]
Added
04/07/2014 at 05:11 PM
- Attendance
[PDF]
Added
04/08/2014 at 10:54 AM
Hearing Record
- Hearing Transcript
[PDF]
Added
04/14/2014 at 04:32 PM
First Published:
March 31, 2014 at 05:22 PM
Last Updated:
May 1, 2015 at 04:19 PM